Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ferrandina

Showing results (11-20 of 176) with videos related to

Pageof 18
Sort By:
British Journal of Cancer|July 1, 1991
Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factorG Scambia, P Benedetti, G Ferrandina, et al.
Oncology|November 24, 2004
Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile?D Lorusso, A Naldini, A Testa, et al.
Gynecologic and Obstetric Investigation|July 28, 2011
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgeryG Ferrandina, A Carbone, G Macchia, et al.
Gynecologic and Obstetric Investigation|June 26, 2013
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literatureM Petrillo, F Legge, G Ferrandina, et al.
Cancer Letters|March 7, 1998
Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancerG Scambia, G Ferrandina, M Distefano, et al.
Gynecologic Oncology|June 28, 2005
Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case reportG Ferrandina, G F Zannoni, V Gallotta, et al.
Anticancer Research|July 1, 1996
Interferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cellsF Iacopino, G Ferrandina, G Scambia, et al.
British Journal of Cancer|January 1, 1997
Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysisG Ferrandina, G Scambia, F Bardelli, et al.
Anticancer Research|November 1, 1989
Growth inhibitory effect of diheptyl diselenide on various human cancer cell linesG Scambia, P B Panici, F Battaglia, et al.
Human Reproduction (Oxford, England)|July 1, 1995
Epidermal growth factor receptors in placentae and fetal membranes from hypertension-complicated pregnanciesG Ferrandina, A Lanzone, G Scambia, et al.
Pageof 18

Showing results (11-20 of 176) with videos related to

Sort By:
Pageof 18
British Journal of Cancer|July 1, 1991
Cathepsin D assay in ovarian cancer: correlation with pathological features and receptors for oestrogen, progesterone and epidermal growth factorG Scambia, P Benedetti, G Ferrandina, et al.
Oncology|November 24, 2004
Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile?D Lorusso, A Naldini, A Testa, et al.
Gynecologic and Obstetric Investigation|July 28, 2011
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgeryG Ferrandina, A Carbone, G Macchia, et al.
Gynecologic and Obstetric Investigation|June 26, 2013
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literatureM Petrillo, F Legge, G Ferrandina, et al.
Cancer Letters|March 7, 1998
Epidermal growth factor receptor (EGFR) is not related to the prognosis of cervical cancerG Scambia, G Ferrandina, M Distefano, et al.
Gynecologic Oncology|June 28, 2005
Progression of conservatively treated endometrial carcinoma after full term pregnancy: a case reportG Ferrandina, G F Zannoni, V Gallotta, et al.
Anticancer Research|July 1, 1996
Interferons inhibit EGF-stimulated cell growth and reduce EGF binding in human breast cancer cellsF Iacopino, G Ferrandina, G Scambia, et al.
British Journal of Cancer|January 1, 1997
Relationship between cathepsin-D content and disease-free survival in node-negative breast cancer patients: a meta-analysisG Ferrandina, G Scambia, F Bardelli, et al.
Anticancer Research|November 1, 1989
Growth inhibitory effect of diheptyl diselenide on various human cancer cell linesG Scambia, P B Panici, F Battaglia, et al.
Human Reproduction (Oxford, England)|July 1, 1995
Epidermal growth factor receptors in placentae and fetal membranes from hypertension-complicated pregnanciesG Ferrandina, A Lanzone, G Scambia, et al.
Pageof 18